NPI: 1356318844 · BRADENTON, FL 34210 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 401 | $81K |
| 2019 | 10,552 | $1.81M |
| 2020 | 18,759 | $2.88M |
| 2021 | 17,570 | $985K |
| 2022 | 16,774 | $1.80M |
| 2023 | 8,300 | $410K |
| 2024 | 1,306 | $76K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,373 | 1,601 | $3.39M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,886 | 1,119 | $2.39M |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,025 | 575 | $697K |
| A4657 | Syringe, with or without needle, each | 3,263 | 1,164 | $512K |
| J1756 | Injection, iron sucrose, 1 mg | 5,531 | 1,018 | $426K |
| 85041 | 1,420 | 858 | $144K | |
| 85048 | 1,417 | 856 | $144K | |
| 83970 | 951 | 599 | $101K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,165 | 559 | $71K |
| 82728 | 486 | 289 | $53K | |
| 83550 | 465 | 272 | $51K | |
| 83540 | 491 | 288 | $51K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 84 | 43 | $6K |
| 82746 | 58 | 40 | $4K | |
| G0008 | Administration of influenza virus vaccine | 24 | 12 | $2K |
| 90674 | 23 | 12 | $2K |